Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas
{{output}}
Small-cell lung cancer (SCLC) transformation accounts for 3-14% of resistance in EGFR-TKI relapsed lung adenocarcinomas (LUADs), with unknown molecular mechanisms and optimal treatment strategies. We performed transcriptomic analyses (including bulk and spatia... ...
